Haimov H, Giron F, Jacobson J H
Arch Surg. 1979 Jun;114(6):673-7. doi: 10.1001/archsurg.1979.01370300027003.
A total of 362 polytetrafluoroethylene (PTFE) grafts were implanted in patients as vascular substitutes in a variety of vascular reconstructive procedures. A total of 184 were used in femoropopliteal bypass operations. Cumulative patency rates showed 74% patency at the end of the first year of observation and 58% after two and three years. Seventeen grafts were used for femorotibial bypasses, with a cumulative patency rate of 40.4% after one year. Ninety-eight grafts were implanted in the upper or lower extremity to serve as vascular access for hemodialysis. For this group, the cumulative one-year patency rate was 83%. Sixty-three additional grafts were implanted in various other anatomic locations. Based on this experience, the PTFE graft seems to be a promising and versatile vascular prosthesis, although it should be used cautiously.
总共362个聚四氟乙烯（PTFE）移植物被植入患者体内，作为各种血管重建手术中的血管替代物。其中184个用于股腘动脉搭桥手术。累积通畅率显示，在观察的第一年结束时通畅率为74%，两年和三年后为58%。17个移植物用于股胫动脉搭桥，一年后的累积通畅率为40.4%。98个移植物被植入上肢或下肢，用作血液透析的血管通路。对于该组，一年的累积通畅率为83%。另外63个移植物被植入其他不同的解剖位置。基于这一经验，聚四氟乙烯移植物似乎是一种有前景且用途广泛的血管假体，尽管应谨慎使用。
